Status:
WITHDRAWN
Dexmedetomidine Versus Pentobarbital for Pediatric Procedural Sedation
Lead Sponsor:
Washington University School of Medicine
Conditions:
Sedation
Eligibility:
All Genders
6-6 years
Phase:
NA
Brief Summary
The investigators believe dexmedetomidine will provide superior sedation with reduced side effects and reduced time to discharge compared with pentobarbital. The investigators have developed sedation ...
Eligibility Criteria
Inclusion
- Requiring sedation for non-painful procedures
- Normal airway per exam
Exclusion
- Congenital syndromes with known difficult airways
- Known difficult airway during past anesthesia or sedation experience
- Parent/guardian refusal of participation
Key Trial Info
Start Date :
November 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2010
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00878345
Start Date
November 1 2009
End Date
June 1 2010
Last Update
June 28 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
St. Louis Children's Hospital
St Louis, Missouri, United States, 63110